These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16412404)

  • 1. Soluble guanylate cyclase (sGC) down-regulation by abnormal extracellular matrix proteins as a novel mechanism in vascular dysfunction: Implications in metabolic syndrome.
    Packer CS
    Cardiovasc Res; 2006 Feb; 69(2):302-3. PubMed ID: 16412404
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
    Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
    Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oxidative-nitrosative stress impairs coronary vasodilation in metabolic syndrome model rats.
    Kagota S; Maruyama K; Tada Y; Fukushima K; Umetani K; Wakuda H; Shinozuka K
    Microvasc Res; 2013 Jul; 88():70-8. PubMed ID: 23571030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
    Radovits T; Korkmaz S; Miesel-Gröschel C; Seidel B; Stasch JP; Merkely B; Karck M; Szabó G
    Eur J Cardiothorac Surg; 2011 Feb; 39(2):248-55. PubMed ID: 20591683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
    Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arg-Gly-Asp (RGD)-containing peptides increase soluble guanylate cyclase in contractile cells.
    Díez-Marqués ML; Ruiz-Torres MP; Griera M; López-Ongil S; Saura M; Rodríguez-Puyol D; Rodríguez-Puyol M
    Cardiovasc Res; 2006 Feb; 69(2):359-69. PubMed ID: 16360131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term.
    Telfer JF; Itoh H; Thomson AJ; Norman JE; Nakao K; Campa JS; Poston L; Tribe RM; Magness RR
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5934-43. PubMed ID: 11739467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema.
    Weissmann N; Lobo B; Pichl A; Parajuli N; Seimetz M; Puig-Pey R; Ferrer E; Peinado VI; Domínguez-Fandos D; Fysikopoulos A; Stasch JP; Ghofrani HA; Coll-Bonfill N; Frey R; Schermuly RT; García-Lucio J; Blanco I; Bednorz M; Tura-Ceide O; Tadele E; Brandes RP; Grimminger J; Klepetko W; Jaksch P; Rodriguez-Roisin R; Seeger W; Grimminger F; Barberà JA
    Am J Respir Crit Care Med; 2014 Jun; 189(11):1359-73. PubMed ID: 24738736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of nitric oxide-dependent guanylate cyclase and reactive oxygen species signaling pathways to desensitization of μ-opioid receptors in the rat locus coeruleus.
    Pablos P; Mendiguren A; Pineda J
    Neuropharmacology; 2015 Dec; 99():422-31. PubMed ID: 26254861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
    Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble guanylate cyclase.
    Poulos TL
    Curr Opin Struct Biol; 2006 Dec; 16(6):736-43. PubMed ID: 17015012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome.
    Kagota S; Tada Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Can J Physiol Pharmacol; 2011 May; 89(5):355-64. PubMed ID: 21619437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal nitric oxide synthase and its interaction with soluble guanylate cyclase is a key factor for the vascular dysfunction of experimental sepsis.
    Nardi GM; Scheschowitsch K; Ammar D; de Oliveira SK; Arruda TB; Assreuy J
    Crit Care Med; 2014 Jun; 42(6):e391-400. PubMed ID: 24717470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia decreases expression of soluble guanylate cyclase in cultured rat pulmonary artery smooth muscle cells.
    Hassoun PM; Filippov G; Fogel M; Donaldson C; Kayyali US; Shimoda LA; Bloch KD
    Am J Respir Cell Mol Biol; 2004 Jun; 30(6):908-13. PubMed ID: 14754757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclase.
    Nedvetsky PI; Meurer S; Opitz N; Nedvetskaya TY; Müller H; Schmidt HH
    FEBS Lett; 2008 Jan; 582(2):327-31. PubMed ID: 18155168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
    Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
    Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and impaired vasomotor reactivity: causal relationship or chance association?
    Tsivgoulis G; Heliopoulos I
    Eur J Neurol; 2010 Dec; 17(12):e108; author reply e109. PubMed ID: 20722708
    [No Abstract]   [Full Text] [Related]  

  • 20. Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction.
    Brioni JD; Nakane M; Hsieh GC; Moreland RB; Kolasa T; Sullivan JP
    Int J Impot Res; 2002 Feb; 14(1):8-14. PubMed ID: 11896472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.